Takeshi Yoshida

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Quantitative evaluation of healthcare information provided to patients with thoracic malignancies: patient satisfaction survey of the Japan Lung Cancer Society.

Quantitative evaluation of healthcare information provided to patients with thoracic malignancies: patient satisfaction survey of the Japan Lung Cancer Society.

Journal: International journal of clinical oncology

Published: October 05, 2025

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

Journal: Molecular and clinical oncology

Published: September 03, 2024

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Journal: Oncology letters

Published: March 16, 2023

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.

Journal: The Journal of clinical investigation

Published: December 22, 2022

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).

Journal: The oncologist

Published: June 22, 2022

Progression from early to advanced stage of immune-related cholangitis.

Progression from early to advanced stage of immune-related cholangitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 24, 2022

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study.

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study.

Journal: JTO clinical and research reports

Published: April 06, 2021

CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.

CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.

Journal: International journal of clinical oncology

Published: January 09, 2021

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer.

Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion-Positive Breast Cancer.

Journal: JCO precision oncology

Published: July 18, 2020

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Journal: The oncologist

Published: June 24, 2020

A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood.

A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood.

Journal: Case reports in oncology

Published: May 03, 2020

Clinical and immune profiling for cancer of unknown primary site.

Clinical and immune profiling for cancer of unknown primary site.

Journal: Journal for immunotherapy of cancer

Published: April 23, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026